The CD4+CD25+FoxP3+ Regulatory T Cells Regulated by MSCs Suppress Plasma Cells in a Mouse Model of Allergic Rhinitis

Ichwan M., Farhat F., Ilyas S., Sembiring R.J., Munir D., Madiadipoera T., Putra A., Restimulia L., Amalina N.D., Alif I.

Abstract

Background: Allergic Rhinitis (AR) is the most common immunological disease that has been associated with inflammatory responses and is characterized by sneezing. Previous studies found that AR's allergen exposure significantly induces plasma cells and reduces regulatory T (Treg) cells, a population that contributes to control AR. Therefore, upregulating Treg expression can regulate plasma cells leading to inhibit sneezing in AR. Mesenchymal stem cells (MSCs) are multipotent stem cells that have the immunoregulatory and antiinflammation ability by secreting various cytokines including IL-10 and TGF-β which potent as a promising therapeutic modality for allergic airway diseases, including AR. Objective: To investigate the role of MSCs in generating CD4+, CD25+, and Foxp3+ Regulatory T cells associated with suppressing plasma cell in AR model. Methods: In this study, fifteen male Wistar rats (6 to 8 weeks old) were randomly divided into three groups (control group, sham group, and MSCs treatment group). OVA nasal challenge was conducted daily from day 15 to 21, and MSCs (1x10<sup>6</sup>) were administrated intraperitoneally to OVA-sensitized rats on day 21. Sneezing was observed from day 22 to 28. The rats were sacrificed on day 22 and day 28. The expression of CD4+ CD25+ Foxp3+ in Treg and plasma cells was analyzed by flow cytometry assay. Results: This study showed that the percentage of plasma cell and sneezing times significantly decreased in MSCs treatment. This finding was aligned with the significant increase of CD4+CD25+Foxp3+ Treg level. Conclusion: MSCs administration suppress plasma cells population and sneezing times by up regulating Treg to control AR.

Journal
Medical Archives
Page Range
256-261
Publication date
2021
Total citations
Cited by 16
Transforming growth factor-β and interleukin-10 synergistically regulate humoral immunity via modulating metabolic signals

Fujio K., Inoue M., Iwasaki Y., Komai T., Morita K., Okamura T., Okamura T., Shoda H., Sumitomo S., Yamamoto K., Yamamoto K., Yamamoto K.

Tregs and allergic disease

Durham S.R., Larche M., Robinson D.S., Robinson D.S.

Subsets of regulatory T cells and their roles in allergy

Guo L., He S., Kong H., Sun X., Zeng X., Zhang H., Zhang H.

Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy

Glenn JD.

Non-classical B Cell Memory of Allergic IgE Responses

Aranda C.J., Curotto de Lafaille M.A., Curotto de Lafaille M.A., Ma E.G.M., Saunders S.P.

No Title

Ankrum James A., Joon Faii Ong JMK.

Interaction between mesenchymal stem cells and B-cells

Cen P., Chen J., Fan L., Hu C., Li L., Wang J., Cen P., Chen J., Fan L., Hu C., Li L., Wang J., Cen P., Chen J., Fan L., Hu C., Li L., Wang J.

Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner

Cho K.-A., Kim Y.-H., Lee J.-K., Park M., Ryu K.-H., Woo S.-Y., Cho K.-A., Kim Y.-H., Lee J.-K., Park M., Ryu K.-H., Woo S.-Y.

Management of Allergic Rhinitis: A Review for the Community Pharmacist

Dolen W.K., May J.R.

Side effects of rhinitis medications

Aaronson D.W.

Hypoxia-conditioned mesenchymal stem cells (MSC) exosomes attenuate ultraviolet-B (UVB)-mediated malondialdehyde (MDA) and matrix metalloproteinase-1 (MMP)-1 upregulation in collagen loss models

Sumarawati T., Putra A., Trisnadi S., Amalina N.D., Setiawan E., Hermansyah D., Angelina J.

Medicinski Glasnik

Mediation Effects of Placental Inflammatory Transcriptional Biomarkers on the Sex-Dependent Associations between Maternal Phthalate Exposure and Infant Allergic Rhinitis: A Population-Based Cohort Study

HUANG K., ZHU P., WANG S.F., LIANG C.M., GAO H., XIA X., LI Z.J., HAO J.H., SHENG J., HU Y.B., TAO F.B., WANG J.Q.

Biomedical and Environmental Sciences

Is mesenchymal stem cell effective for allergic rhinitis? A protocol for a systematic review and meta-analysis

Zhang Q., Yan L., Dai L., Zhang H., Zheng H.

BMJ Open

Clitorea ternatea flower extract induces platelet-derived growth factor (Pdgf) and gpx gene overexpression in ultraviolet (uv) b irradiationinduced collagen loss

Darlan D.M., Chodidjah, Putra A., Thomas S., Trisnadi S., Amalina N.D., Putri R.S., Irawan R.C.

Medicinski Glasnik

Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis

Zhang L., Zhao N., Wang M., Wang C., Jin Z.-B.

Allergy European Journal of Allergy and Clinical Immunology

Secretome of hypoxia-preconditioned mesenchymal stem cells enhance the expression of HIF-1a and bFGF in a rotator cuff tear model

Ismiarto Y.D., Putra A., Amalina N.D., Alif I., Nazar M.A., Fredianto M., Herman H.

Medicinski Glasnik

The role of mesenchymal stem cells in allergic rhinitis and its relationship with IL-10, plasma cells and regulatory T cells

Nasution I.P., Munir D., Putra A., Restimulia L., Amalina N.D.

Medicinski Glasnik

Hypoxic secretome mesenchymal stem cells inhibiting interleukin-6 expression prevent oxidative stress in type 1 diabetes mellitus

Putra A., Wibowo J.W., Amalina N.D., Irawan R.C.S., Utami A.

Medicinski Glasnik

Extracellular vesicles from adipose stem cells ameliorate allergic rhinitis in mice by immunomodulatory

Wang L., Deng D., Fan K., Gao Z., Zhang Z., lai J., Yang W., Zhang J., Zhou S., Pan Z., Yu S.

Frontiers in Immunology

Hypoxic mesenchymal stem cells (MSCS)-induced interleukin (IL)-10 alleviate systemic lupus erythematosus (SLE) inflammation through inhibiting interferon (IFN)-gamma production

Wisnu Prajoko Y., Putra A., Prasetio A., Dina Amalina N.

Medicinski Glasnik

Access to Document

10.5455/medarh.2021.75.256-261